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httpAbdominal aortic aneurysms in women
Jean E. Starr, MD, FACS,a and Vivienne Halpern, MD, FACS,b Columbus, Ohio; and Phoenix, Ariz
Abdominal aortic aneurysms have an incidence that is approximately four to six times higher in men than in women.
However, the incidence in women also rises with older age, although starting later in life than in men. There are also sex
differences in the risk of rupture and in outcomes after endovascular and open abdominal aortic aneurysm repair. Various
explanations have been proposed. Women historically have been under-represented in clinical trials to evaluate the
differences between the sexes. We present a review of current recommendations and recent literature to help identify some
of these differences. (J Vasc Surg 2013;57:3S-10S.)Abdominal aortic aneurysms (AAAs) are known to
have an incidence that is approximately four to six times
higher in men than in women. However, the incidence in
women also rises with age, although starting later in life
than in men. There are also sex differences in the risk of
rupture and in outcomes after endovascular and open
AAA repair. Here, we present a review of current recom-
mendations and the literature to help identify some of these
differences.
PATHOPHYSIOLOGY OF SEX DIFFERENCES
Some of the observed sex differences in AAA incidence
may be related to the protective effects of estrogen against
aneurysm development as well as the negative effects of
testosterone on the aorta, as is supported by results in
several animal models.
McNulty et al1 demonstrated in 2004 that 17-b-estra-
diol slowed the development of angiotensin II-induced
AAAs in apolipoprotein-deﬁcient mice. Henriques et al2
similarly demonstrated that orchiectomy but not oophorec-
tomy decreased aneurysm growth in the samemodel of AAA
development. Ailawadi et al3 demonstrated that male rats
developed larger AAAs than female rats in the elastase
perfusion model of AAA. In addition, there was increased
macrophage inﬁltration and levels of matrix metalloprotei-
nase (MMP)-9, as evidenced by immunohistochemical
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://dx.doi.org/10.1016/j.jvs.2012.08.125interestingly, female rat aortas transplanted into male rats
lost their resistance to aneurysm growth and were equivalent
to control males. Female-to-female transplants retained the
resistance to AAA development. Again, these differences
were associated with differences in macrophage inﬁltration
and MMP-9 levels. In addition, when 17-b-estradiol pellets
were implanted in the necks of male rats, there was dimin-
ished growth of aneurysms, less elastin fragmentation, and
diminished macrophage inﬁltration and MMP-9 levels.3
Further evidence was shown by Wu et al,4 who found that
oophorectomized female rats had increased growth of
AAAs in the elastase perfusionmodel compared with oopho-
rectomized females and male rats who received 17-b-estra-
diol pellets. This was associated with increased levels of
MMP-2 and MMP-9 expression.4
The role of testosterone in promoting aneurysm forma-
tion was further investigated by Henriques et al5 in 2008 in
the angiotensin IIeinduced AAA model. They found that
the aortic angiotensin II type A1 receptor was eight times
more abundant in the abdominal aorta of male mice than in
female mice. They demonstrated in orchiectomized males
that the number of these receptors diminished but were
restored by giving dihydrotestosterone (DHT) and that
giving DHT increased the incidence of AAA formation in
orchiectomized males as well as in females. To further
this evidence, Cho et al6 demonstrated in 2009 that in
orchiectomized male rats and oophorectomized female
rats, the experimental male rats had a signiﬁcantly
decreased growth of aneurysm than did control males.
There was no signiﬁcant difference in the oophorectom-
ized females compared with controls; however, the oopho-
rectomized females who were given back estrogen,
compared with those who were not, had a signiﬁcant
decrease in aortic growth. AAA growth increased in male
rats that underwent orchiectomy and received testosterone
pellets. Interestingly, when testosterone pellets were
implanted in control male rats, there was a 30% increased
incidence of rupture during the experiments compared
with control male rats that were not given testosterone.6
The idea that estrogen may be protective is also sup-
ported in humans by the analysis by the 2008 Lederle
et al7 data from the Women’s Health Initiative, which
showed a lower incidence of AAA events (repairs and
ruptures) in women taking hormone replacement therapy.3S
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humans is not as clear. The only study to address this in
humans was by Yeap et al8 in Australia. They found that
lower free testosterone and higher luteinizing hormone
levels were associated with increased AAA incidence in
older men, which is contrary to the ﬁndings in the various
animal models.8
All of these studies demonstrate that there is likely an
aspect of hormonal regulation in the development of
AAAs that could explain the sex differences, but the exact
mechanisms are still unclear. Future studies are needed to
further elucidate the exact nature the effect of sex
hormones on AAA development.
AAA SCREENING
Current recommendations and prevalence. In
February 2005, the United States Preventive Services Task
Force (USPSTF) released its summary of recommendations
for AAA screening.9 The summary of recommendations is
listed in Table I, and the grade ranking and quality of
evidence ratings are deﬁned in Table II. The USPSTF rec-
ommended against routine screening in women because the
prevalence of AAAs in women is very low and the number of
deaths that could be prevented was small. It also suggested
that the harm of routine screening outweighed the beneﬁts
due to the potential morbidity and mortality to women
undergoing an increased number of surgeries for AAAs as
well as psychologic harms incurred. TheUSPSTF noted that
most AAA-related deaths occur in women aged >80 years
and that screening would not be beneﬁcial because of the
increased concomitant risk factors at this age. Individuali-
zation of care, however, was still recommended. This issue of
screening women for AAAs has not been readdressed since
the USPSTF recommendations were released.
The USPSTF recommendations were mostly based on
a best-evidence systematic review.10 This document con-
sisted of the review of only four population-based random-
ized, controlled trials of AAA screening, each with
a different study design and with data collection mostly
from men. The Multicentre Aneurysm Screening Study
(MASS) dominated the pooled data over the other three
studies due to the higher volume of patients enrolled.
These trials were not conducted in the United States, so
it is unclear how this may translate to United States popu-
lations. In addition, little speciﬁc information is available on
racial and ethnic groups, age distributions, or women,
except in isolated reports within the USPSTF recommen-
dations. No physical harm from the ultrasound screenings
was reported, and any psychologic or diminished general
health perception did not last long. The question also arises
regarding the accuracy of cause of death when information
is obtained from death certiﬁcates. Personalized decision
making regarding screening should take into account
a patient’s individual risks as well as willingness to accept
potential beneﬁts and adverse effects.
The United Kingdom Chichester study11 recruited
9342 women and 6433 men aged 65 to 80 years for AAA
screening. AAA prevalence was six times lower in womenthan in men (1.3% vs 7.6%). The investigators recommen-
ded against screening for AAAs in women due to the low
prevalence. Overall, 3052 women presented for screening
because half were randomized to the control group of no
screening. No reduction in AAA ruptures was found in the
screened group at 5- and 10-year intervals; however, the
denominator used for the screening group was all of those
randomized to screening, including 1630 women who did
not actually attend a screening. Also, at least partial data
collection was from death certiﬁcates; therefore, cause-of-
death determination may be inaccurate when based on ofﬁ-
cial statistics and not on actual autopsy ﬁndings.
The Stroke and Aneurysm Vascular Evaluation (SAVE)
program (Medtronic Inc, Minneapolis, Minn) conducted
a volunteer screening that was attended by 10,012 women
and 7528 men. The results were evaluated by DeRubertis
et al12 from New York Presbyterian Hospital. Although
the AAA prevalence rate in women was conﬁrmed to be
lower (0.7% vs 3.9%), subgroups were identiﬁed that had
elevated AAA rates. On the basis of these ﬁndings, screening
for AAAs should be considered in women aged >65 years
and women with a history or smoking or cardiovascular
disease.
Life Line Screening medical and lifestyle questionnaire
and ultrasound imaging results from 2003 to 2008 were
evaluated in 3.1 million patients.13 A scoring system to
predict AAAs was created and was felt to identify AAAs
more efﬁciently and include groups excluded from the
USPSTF inclusion criteria for screening. This study esti-
mated a national prevalence of 1.1 million AAAs (1.4%
for those aged 50-84 years): 569,000 occurring in women,
nonsmokers, and individuals aged <65 years. USPSTF
criteria would identify only 29.5% of all AAAs due to the
current selection criteria and does not identify AAAs in
women, nonsmokers, and younger patients. The proposed
scoring system would ﬁnd 88.6% of AAAs in the group
aged 50 to 84 years old. Although women represent only
20% of AAAs, they have demonstrated a three times higher
rupture occurrence and a similar number of AAA deaths as
men.14 This suggests that women are not being appropri-
ately diagnosed or are not being offered AAA repair at
a time when repair might be safer and effective at prevent-
ing rupture. Obviously, recognizing women at risk with
improved and more efﬁcacious screening methods would
potentially help to decrease the morbidity and mortality
from rupture and late identiﬁcation.
Risk factors and associations. Although one may not
conclude that routine AAA screening should be instituted
for all women according to prevalence alone, other consid-
erations should be taken into account. Rupture rates are
reportedly higher in women than in men. The United
Kingdom Small Aneurysm Trial15 showed women had
a threefold higher rupture rate than men, even after
adjustment for age, initial AAA diameter, and body mass
index or height. In addition, the mean diameter at rupture
for women was 5.0 cm compared with an average diameter
of 6.0 cm in men. This may be accounted for by differences
in biomechanical properties of AAAs between men and
Table II. United States Preventive Services Task Force (USPSTF) grade deﬁnitions and quality of evidencea
Variable Deﬁnition
Grade of deﬁnitionsb
A: Strongly recommended The USPSTF strongly recommends that clinicians provide [the service] to eligible patients.
The USPSTF found good evidence that [the service] improves important health outcomes
and concludes that beneﬁts substantially outweigh harms.
B: Recommended The USPSTF recommends that clinicians provide [the service] to eligible patients. The USPSTF
found at least fair evidence that [the service] improves important health outcomes and
concludes that beneﬁts outweigh harms.
C: No recommendation The USPSTF makes no recommendation for or against routine provision of [the service]. The
USPSTF found at least fair evidence that [the service] can improve health outcomes but
concludes that the balance of beneﬁts and harms is too close to justify a general recommendation.
D: Not recommended The USPSTF recommends against routinely providing [the service] to asymptomatic patients.
The USPSTF found at least fair evidence that [the service] is ineffective or that harms
outweigh beneﬁts.
I: Insufﬁcient evidence to
make a recommendation
The USPSTF concludes that the evidence is insufﬁcient to recommend for or against routinely
providing [the service]. Evidence that the [service] is effective is lacking, of poor quality, or
conﬂicting and the balance of beneﬁts and harms cannot be determined.
Quality of evidence
Good Evidence includes consistent results from well-designed, well-conducted studies in representative
populations that directly assess effects on health outcomes.
Fair Evidence is sufﬁcient to determine effects on health outcomes, but the strength of the evidence
is limited by the number, quality, or consistency of the individual studies, generalizability to
routine practice, or indirect nature of the evidence on health outcomes.
Poor Evidence is insufﬁcient to assess the effects on health outcomes because of limited number or
power of studies, important ﬂaws in their design or conduct, gaps in the chain of evidence,
or lack of information on important health outcomes.
aAvailable at http://www.uspreventiveservicestaskforce.org/uspstf/gradespre.htm#brec.
bApplies to recommendations voted on by the USPSTF before May 2007.
Table I. United States Preventive Services Task Force (USPSTF) summary of recommendations for abdominal aortic
aneurysm (AAA) screeninga
USPSTF recommendation Grade of recommendation Quality of evidence
One-time screening for AAAs by ultrasound imaging in men
aged 65 to 75 who have ever smoked
B Fair
No recommendation for or against screening
for AAAs in men aged 65 to 75 who have never smoked
C Fair
No routine screening for AAAs in women D Fair
aAvailable at http://www.uspreventiveservicestaskforce.org/uspstf05/aaascr/aaars.htm.
JOURNAL OF VASCULAR SURGERY
Volume 57, Number 4S Starr and Halpern 5Swomen. Vande Geest et al16 demonstrated a trend toward
a decrease in tensile strength in AAA wall specimens in
women compared with those taken from men, although
this was not statistically signiﬁcant.
It has also been suggested that baseline normal aortic
diameter may be smaller in women than in men. The
Tromso Study17 monitored 4265 men and women with
normally sized aortas for the development of AAAs during
a 7-year period. The maximal aortic diameter at baseline
was 19.4 mm in women vs 21.8 mm in men. Men were
noted to have a statistically signiﬁcant higher risk of devel-
oping AAAs during the follow-up period. The greater
aortic size at baseline was implicated in the future develop-
ment of AAAs; however, the question remains if smaller
AAAs in women have the same signiﬁcance as larger
AAAs in men. The Aneurysm Detection and Management
(ADAM) Veterans Affairs (VA) Cooperative Study18 notedfemale gender was associated with a 0.14-cm reduction in
aortic diameter. This difference was small but did reach
statistical signiﬁcance.
Aortic diameters at all levels were measured in 389
computed tomography scans reviewed at Northwestern.19
Diameters were a function of age, sex (with men having
larger aortas), and body surface area. This may again raise
the concern of waiting to repair AAAs in women until
they reach the same average size of AAAs in men. In addi-
tion, women present at an older age than men with simi-
larly sized small AAAs.20 This translates into women
undergoing repair at an older age, with possible increased
risks. The same group from Kingston, Ontario, Canada,
examined the risk of rupture in untreated AAAs with atten-
tion to sex differences.21 Women had a four times higher
risk of rupture than men with AAAs of 5.0 to 5.9 cm
(3.9% vs 0.8%). This would support an earlier intervention
JOURNAL OF VASCULAR SURGERY
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and re-emphasizes the importance of including women in
AAA screening programs.
Aside from pure size indications for repair, other risk
factors have been shown to be associated with AAA devel-
opment, especially in women, and therefore have potential
implications for favoring screening. The Women’s Health
Initiative Study Group enrolled 161,808 postmenopausal
women from 1993 to 1998 and monitored them until
the end of the study in 2005.7 A total of 184 AAA events
were found and were strongly associated with age and
smoking. Height, hypertension, cholesterol-lowering treat-
ment, coronary artery disease, and peripheral arterial
disease also had positive but weaker associations. Hormone
replacement and diabetes (previously reported to have
a positive association in men) had a negative association
in women.
Powel and Norman,22 in an editorial response to the
Women’s Health Initiative ﬁndings, pointed out that
smoking became popular for women 3 decades after
men, and therefore, we may just now be realizing the
effects in women. This would suggest that screening for
AAAs may now be justiﬁed in women who have smoked
and that public health initiatives should be aimed at
smoking cessation in women. The authors also suggest
that estrogens may decrease the risk of AAA formation
by reducing AAA MMP expression.
Another proposed association in women with AAAs is
cerebral vascular disease. The ADAM VA study screened
122,272 male and 3450 female veterans and found an inci-
dence of 4.3% in men and 1.0% in women.23 The association
of AAAs with cerebral vascular disease had been suggested
previously but was conﬁrmed in the larger ADAM study.
Lastly, advancing age has been suggested as a risk
factor for AAA development as well as rupture. A French
study24 examined women from mutiplex AAA families
and found that affected female relatives were signiﬁcantly
older at diagnosis and surgery than men. It was suggested
that men and women in families with more than two
people affected with AAAs should both undergo routine
screening, although the women became affected 10 years
later than the men. This may raise concerns for routine
AAA repair in a population of advanced age with an
increasing number of comorbidities.
Cost-effectiveness. MASS conducted a randomized
trial of screening vs nonscreening for AAAs and a subsequent
10-year follow-up analysis in 67,770 men.25 The mortality
beneﬁt seen in the early portion of the study continued
throughout this latter portion, with a relative 48% risk
reduction for AAA-related deaths. Cost-effectiveness also
became more favorable over time. Attendance at screenings
should be encouraged, with subsequent clinical follow-up in
those found to have AAAs. Attention to a low operative
mortality and morbidity was also emphasized. Unfortu-
nately, no cost-effectiveness data are available for women in
this study because none were screened.
The cost-effectiveness analyses for the USPSTF26
included four studies that addressed appropriate economicevaluation. None of these (including MASS) addressed any
cost-effectiveness for AAA screening speciﬁcally in women.
Wanhainen et al,27 however, found 18 suitable studies
with female-speciﬁc data that were appropriate for use in
the Markov cohort simulation model, which has been used
to evaluate the cost-effectiveness of AAA screening in men.
They found the incremental cost-effectiveness ratio for
AAA screening in women was similar to that found in
men. This may show that the lower AAA prevalence rate in
women is balanced by a higher rupture rate and that exclu-
sion of women from routine AAA screenings is not justiﬁed.
Society recommendations. Overall, ultrasound
screening has been shown to reduce AAA-related mor-
tality. The Society for Vascular Surgery has also recom-
mended ultrasound screening for women aged >65 years
who have smoked or have a family history of AAAs.28 The
level of recommendation was strong, with moderate quality
of evidence. Although surveillance was recommended for
most patients with an aneurysm of 4.0 to 5.4 cm, women
with a slightly smaller aneurysm of 5.0 to 5.4 cm should be
considered for earlier repair. Lastly, the SVS Executive
Summary recognized the need for further research in
several areas, including screening for AAAs in women and
minorities. It would seem reasonable for now to include
women in screening efforts until more data become avail-
able to help deﬁne the future role of AAA screening in this
group. AAAs in women clearly behave differently, and
more information on the natural history of AAAs in women
is needed because a paucity of data exists.ENDOVASCULAR AAA REPAIR OUTCOME
A less invasive approach to AAA repair may prove to be
a better option for women, especially those of advanced
age with signiﬁcant comorbidities. Unfortunately, fewer
women undergo endovascular AAA repair (EVAR) than
men, ranging from 12% to 26% in recent series.29-32 Anal-
ysis of the American College of Surgeons National Surgical
Quality Improvement Program (NSQIP) data set of
3662 EVARs revealed that 17.7% were women.33 Al-
though this type of study does not always lend itself to
the evaluation of underlying contributing factors, the
authors suggested that future studies should address aneu-
rysm anatomic details. In addition, this deserves investiga-
tion to elucidate the reasons why more women do not
undergo EVAR and why more women are likely to present
more physically debilitated and with ruptured AAAs. The
NSQIP data only reﬂect 30-day outcome, and therefore,
longitudinal studies would be of importance to determine
late outcome from EVAR in women.
AAA neck conﬁguration is the most common anatomic
feature that prohibits aortic endograft placement. Women
have been found to have narrower and shorter necks, as
well as narrower iliac arteries with a higher calciﬁcation
score.2 A review of selection criteria for the Zenith AAA
endovascular graft (Cook Inc, Bloomington, Ind) revealed
that in patients who did not qualify for EVAR, the unsuit-
ability was due to the proximal neck anatomy in 88%;
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women.34 Inadequate neck length (15 mm) was the
most common criterion within this group. Wolf et al31
also discovered that the mean diameters of the proximal
neck, common iliac, and external iliac arteries were all
smaller in women. In addition, the length of the proximal
neck was shorter. One might conclude that a smaller prox-
imal neck diameter might coincide with a smaller AAA
diameter; however, at least two studies found that the
AAA diameter between men and women undergoing
EVAR was actually similar.29,31
Certainly, there are other factors that potentially
contribute to women undergoing EVAR less frequently.
As noted from screening studies, women who undergo
EVAR tend to be older than men,29-31 and Becker et al32
reported that perioperative EVAR survivors were signiﬁ-
cantly younger, although this information was not stratiﬁed
by sex. NSQIP data analysis33 also revealed that women
had a higher incidence of ﬁve preoperative risk factors for
morbidity and mortality, including emergency operation,
functional dependence, recent weight loss, underweight
status or morbid obesity, and severe chronic obstructive
pulmonary disease. Women were conﬁrmed to have
a signiﬁcantly higher rate of chronic obstructive pulmonary
disease in the Wolf et al study.31
Assessment of actual EVAR procedures showed more
procedures are aborted in women (16.7% vs 2.1%), but
conversion to open repair was similar.35 Deployment
success was also signiﬁcantly higher in men than in women.
Short-term outcome in those completing repair, however,
was not signiﬁcantly different, and there were similar early
endoleak rates. There was a trend toward longer ﬂuoros-
copy times in women undergoing EVAR in the Mayo
Clinic series.29
The Stanford group31 discovered a higher rate of intra-
operative complications in women, mostly related to arte-
rial access, with iliac avulsion and occlusion requiring
more frequent arterial reconstruction. Despite this, they
also determined that there was no difference between
men and women in the rate of postoperative complications
or death. During a 14-month mean follow-up, no gender-
related differences were noted in survival, endoleak rate,
reintervention rate, or rate of change of AAA diameter or
volume. Mathison et al35 also conﬁrmed a lack of difference
between men and women in perioperative mortality and
major complication rates. The European Collaborators on
Stent-Graft Techniques for AAA and Thoracic Aortic
Aneurysm and Dissection Repair (EUROSTAR) data
registry assessment of the early success rate of 1554 EVARs
deemed female gender and age >70 years to be risk factors
for primary endoleak.36
The Oschner Clinic group reviewed their experience
with 101 men and 17 women undergoing EVAR37 and
found a signiﬁcantly longer length of procedure in women
and a higher arterial dissection rate. Contrary to other
reports, mortality and complication rates at 1 month
were also higher in women. The NSQIP data set33 revealed
that female gender was indeed an independent risk factorfor length of stay, infection, wound complications, and
postoperative transfusion. These data, however, do not
assess intermediate-term or longer-term outcome. Data
from the Nationwide Inpatient Sample (NIS)38 revealed
that mortality was greater in women with intact AAAs
undergoing EVAR and open repairs than in men.
Few data exist to assess the long-term outcome of
EVAR speciﬁcally in women. The Mayo Clinic series29 of
241 patients (12% women) found the postoperative
outcomes at 2 years were similar between men and women,
with a nonsigniﬁcant trend toward a higher rate of aortic
neck dilatation in women. Men actually trended toward
a lower limb patency rate. In contrast, a signiﬁcantly higher
graft limb occlusion rate occurred in women at 2 years in
a Cleveland Clinic series.30 This was felt not to be related
to iliac diameter but was potentially caused by intimal
hyperplasia due to injury during deployment or to differ-
ences in thrombotic tendencies. They also discovered that
although endoleak frequency and type were no different
between men and women, sac shrinkage was more rapid
at 2 years in women.
ELECTIVE OPEN AAA REPAIR OUTCOME
Similar to EVAR, sex differences seem to exist in
patients undergoing elective open AAA repair. The Michi-
gan inpatient database studied outcomes from 1980 to
1990 in 11,512 women and 29,846 men, aged $50 years,
with a diagnosis of intact or ruptured AAA.39 Hospitaliza-
tion for AAA was ﬁve times more common for men, and
they were 1.8 times more likely to undergo surgery for
intact AAAs than women. This and other differences
prompted the authors to recommend a prospective study.
There may also be a difference between the sexes in
regard to demographics. The Canadian Society for
Vascular Surgery Aneurysm Study Group examined the
inﬂuence of gender on results of AAA repair.40 Women
represented 19.7% of intact AAA repairs and were more
likely to be older, have never smoked, have a positive family
history of AAAs, and have a coexisting history of aortoiliac
occlusive disease. Fewer women had electrocardiographic
evidence of an old myocardial infarction or a history of
femoral-popliteal aneurysms. The average AAA size in
women was also smaller. These differences may help us
identify and manage women with AAAs.
Various studies have analyzed outcomes pertaining to
the sexes. An NIS study reviewed 220,403 patient
discharges and found women with an intact AAA had
higher odds of inpatient death38; unfortunately, no expla-
nation could be extracted from the data. A similar Centers
for Medicare and Medicaid Services inpatient sample study
sought to determine if outcomes have been equal between
men and women.41 Although improvements have been
made overall, increasing age, female sex, and open repair
were predictors of elective and ruptured AAA repair
mortality. Men were also more likely to be discharged to
home.
Speziale et al42 sought to identify factors that predicted
postoperative renal failure. Female sex and a preoperative
JOURNAL OF VASCULAR SURGERY
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features.
A Swedish single-center retrospective study found
a higher standardized mortality ratio for women than for
men, and thus, a shorter survival when compared with
the age-matched general population.43 Similarly, another
survival study discovered that the standardized mortality
ratio was increased for both sexes after AAA repair
compared with the general public, but the ratio was higher
for women.44 This was felt to potentially be secondary to
a higher aneurysm-related death in women.
Long-term survival may also be worse in women than
in men. Norman et al45 showed a worse 5-year survival
in women than in men, but this was postulated to be due
to greater cardiovascular morbidity in women. They
acknowledged that women were also under-represented
in statin trials, thereby resulting in this potentially protec-
tive drug being prescribed less frequently to women.
There are studies, however, whose results have
conﬂicted with those that showed worse outcome for
women after elective AAA repair. One review of multiple
population-based reports discovered there was indeed
a discrepancy in results, with some studies showing similar
perioperative mortality and others ﬁnding higher mortality
for women undergoing elective AAA repair.46 In some
studies, very low numbers of women were evaluated and
treated. It was recommended that clinical research be
pursued to determine sex-speciﬁc guidelines for the timing
of AAA repair and why women undergo AAA repair less
commonly. Starr et al47 found that the 5% perioperative
death rate was similar for men and women. Men and
women also possessed similar cardiac risks.
RUPTURED OPEN AAA REPAIR OUTCOME
Several reviews found women were less likely to
undergo surgical treatment of ruptured AAAs.37,48-50 No
uniﬁed explanation has been hypothesized. A review of
the U.K. Lothian Surgical Audit database found women
who were not operated on tended to be older, and older
women (>60 years) were less likely to be offered repair
or undergo repair.51 The diagnosis of ruptured AAAs in
women may be delayed, leading to a late presentation for
treatment and a more advanced, moribund state. Women’s
overall health may also be inappropriately interpreted as
worse than men, leading to repair being offered less
frequently. However, gender was not found to inﬂuence
perioperative mortality in men and women who had under-
gone surgery. The question still stands if a sex bias exists in
selecting women for surgery.
Women have been found to have worse outcomes after
ruptured AAA repair. Total admissions for ruptured AAA
repair for women are 40% that for men, but there has
been an increase of 0.5% annually since 2005.45 Women
tend to be underdiagnosed and undertreated, and this
may account for the trend toward a worse prognosis for
women with ruptured AAAs. The Centers for Medicare
and Medicaid Services 10-year inpatient sample study
showed the average ruptured AAA mortality rate washigher in women (52.8% vs 44.2%).41 The rate of ruptured
AAA repairs also decreased more in men than in women
during the study period of 1994 to 2003. The NIS study,
reviewed above for open AAA results, also examined the
effect of gender on ruptured AAA outcomes from 2001
to 2004.38 Rupture was the indication for 17% of all
aneurysm repairs and a higher percentage of women with
AAAs presented with rupture than men. Unfortunately,
this has not decreased over time. Women were less likely
to undergo surgical repair of a ruptured AAA and also
had higher inpatient mortality after repair. Again, due to
the nature of this type of study, reasons for these differ-
ences could not be elicited.
The Michigan inpatient database, previously reviewed
for elective AAA repair, also found men were 1.4 times
more likely than women to undergo open surgery for
a ruptured AAA.39 Women had a 1.45 times greater chance
than men of dying after surgery for a ruptured AAA.
Another Canadian study of 3570 patients with ruptured
AAAs, with 73% undergoing repair in Ontario, showed
that men were signiﬁcantly more likely to undergo repair
than women (80% vs 58%).48 Women were signiﬁcantly
older than men, but the Charlson Comorbidity Index score
was similar; therefore, the women were no sicker than the
men. Men did receive care in higher-volume hospitals and
in larger cities, implying a potential survival advantage.
The Western Australia Health Services Research Data-
base examined the results of ruptured AAAs in 648 men
and 225 women; of whom, 37% of women and 63% of
men underwent operation.49 Women were on average 6
years older than men when they presented with ruptured
AAA. The overall mortality was 90% for women and 76%
for men. Increased perioperative mortality in women was
speculated to be related to advanced age.46
Despite the differences in immediate-term and short-
term mortality between men and women, long-term
survival has been found to be comparable.40,51 Potential
reasons for these differences have been given above. This
supports the concept that intervening earlier and more
frequently on women with ruptured AAAs may confer
survival beneﬁts in the short term and long term.
CONCLUSIONS
Although the actual underlying pathophysiologic
mechanisms responsible for the difference in AAA preva-
lence in men vs women have not been determined, clearly,
there are sex-speciﬁc risks that women possess. It is reason-
able to recommend routine screening for women aged >65
years who have ever smoked or who have a family history of
AAAs. Research shows that women undergo endovascular,
open, and emergency AAA repair less frequently than men.
Outcome results have varied, but some studies have shown
that short-term and long-term results between men and
women are similar, even though women present later and
have a higher rupture rate. Certainly, focused sex-speciﬁc
research is warranted to elucidate the reasons for differ-
ences between men and women and to attempt to provide
the best medical care for everyone.
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